Effects of Sacubitril/Valsartan Versus Olmesartan on Central Hemodynamics in the Elderly With Systolic Hypertension
Authors:
- Bryan WilliamsBWBryan Williams
- John R. CockcroftJCJohn R. Cockcroft
- Kazuomi KarioKKKazuomi Kario
- Dion H. ZappeDZDion H. Zappe
- Patrick C. BrunelPBPatrick C. Brunel
- Qian WangQWQian Wang
- Weinong GuoWGWeinong Guo
Top Cited Papers
- 1 March 2017
- journal article
- research article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 69 (3) , 411-420
Abstract
Effective treatment of systolic hypertension in elderly patients remains a major therapeutic challenge. A multicenter, double-blind, randomized controlled trial with sacubitril/valsartan (LCZ696), a first-in-class angiotensin receptor neprilysin inhibitor, was conducted to determine its effects versus olmesartan (angiotensin receptor blocker) on central aortic pressures, in elderly patients (aged ≥60 years) with systolic hypertension and pulse pressure >60 mm Hg, indicative of arterial stiffness. Patients (n=454; mean age, 67.7 years; mean seated systolic blood pressure, 158.6 mm Hg; mean seated pulse pressure, 69.7 mm Hg) were randomized to receive once-daily sacubitril/valsartan 200 mg or olmesartan 20 mg, force titrated to double the initial doses after 4 weeks, before primary assessment at 12 weeks. The study extended double-blind treatment for 12 to 52 weeks, during which amlodipine (2.5–5 mg) and subsequently hydrochlorothiazide (6.25–25 mg) were added-on for patients not achieving blood pressure target (P =0.010), further corroborated by secondary assessments at week 12 (central aortic pulse pressure, −2.4 mm Hg, P P P P <0.002). Both treatments were equally well tolerated. The PARAMETER study (Prospective Comparison of Angiotensin Receptor Neprilysin Inhibitor With Angiotensin Receptor Blocker Measuring Arterial Stiffness in the Elderly), for the first time, demonstrated superiority of sacubitril/valsartan versus olmesartan in reducing clinic and ambulatory central aortic and brachial pressures in elderly patients with systolic hypertension and stiff arteries.Keywords
This publication has 45 references indexed in Scilit:
- Arterial stiffness and chronic kidney diseaseCurrent Opinion in Nephrology and Hypertension, 2015
- Arterial Stiffness, Central Pressures, and Incident Hospitalized Heart Failure in the Chronic Renal Insufficiency Cohort StudyCirculation: Heart Failure, 2014
- Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1·25 million peopleThe Lancet, 2014
- Pulse pressure and risk of cardiovascular outcomes in patients with hypertension and coronary artery disease: an INternational VErapamil SR-trandolapril STudy (INVEST) analysisEuropean Heart Journal, 2009
- Single Versus Combined Blood Pressure Components and Risk for Cardiovascular DiseaseCirculation, 2009
- Systolic pressure is all that mattersThe Lancet, 2008
- Pulse pressure as a risk factor.Clinical and Experimental Hypertension, 2004
- Systolic Blood Pressure, Diastolic Blood Pressure, and Pulse Pressure as Predictors of Risk for Congestive Heart Failure in the Framingham Heart StudyAnnals of Internal Medicine, 2003
- Pulse Pressure and Cardiovascular Disease–Related MortalityJAMA, 2002
- Systolic Blood Pressure, Arterial Rigidity, and Risk of StrokeJAMA, 1981